BACLOFEN 5 MG TABLET
For 30 tablets
Pharmacies pay
$2.04 filed
30 × $0.06798 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$5.60 filed
30 × $0.18654 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.7× estimated
Medicare paid 2.7× what pharmacies pay.
Part D averages every strength and form sold under “Baclofen*” / “Baclofen” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$7.35 estimated
$2.04 + $0.31 (15%) + $5.00 fee per fill = $7.35
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BACLOFEN 5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as baclofen.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.
FDA’s Established Pharmacologic Class for it is gamma-Aminobutyric Acid-ergic Agonist.
The NADAC file of 2026-10-14 prices it under 20 NDCs (National Drug Codes); the FDA directory lists 16 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.04 for 30 tablets (30 × $0.06798 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Method Pharmaceuticals LLC | 3 | $0.06798 per EA filed |
| Advagen Pharma Limited | 1 | $0.06798 per EA filed |
| American Health Packaging | 1 | $0.06798 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.06798 per EA filed |
| AvPAK | 1 | $0.06798 per EA filed |
| Chartwell RX, LLC | 1 | $0.06798 per EA filed |
| Eywa Pharma Inc | 1 | $0.06798 per EA filed |
| Lannett Company, Inc. | 1 | $0.06798 per EA filed |
| Lifestar Pharma LLC | 1 | $0.06798 per EA filed |
| Major Pharmaceuticals | 1 | $0.06798 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.06798 per EA filed |
| TruPharma LLC | 1 | $0.06798 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 1 | $0.06798 per EA filed |
| Zydus Pharmaceuticals (USA) Inc. | 1 | $0.06798 per EA filed |
| Not listed as a package in the FDA directory | 4 | $0.06798 per EA filed |
All 20 NDCs, with labeler and price
- 00527-1333-01 · Lannett Company, Inc. · $0.06798 per EA · eff. 2026-09-23 filed
- 00904-7558-06 · Major Pharmaceuticals · $0.06798 per EA · eff. 2026-09-23 filed
- 16571-0169-01 · Rising Pharma Holdings, Inc. · $0.06798 per EA · eff. 2026-09-23 filed
- 29300-0474-01 · Unichem Pharmaceuticals (USA), Inc. · $0.06798 per EA · eff. 2026-09-23 filed
- 31722-0138-01 · not listed as a package in the FDA directory · $0.06798 per EA · eff. 2026-09-23 filed
- 50268-0105-11 · not listed as a package in the FDA directory · $0.06798 per EA · eff. 2026-09-23 filed
- 50268-0105-15 · AvPAK · $0.06798 per EA · eff. 2026-09-23 filed
- 52817-0319-10 · TruPharma LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 58657-0730-01 · Method Pharmaceuticals LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 58657-0930-01 · Method Pharmaceuticals LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 58657-0930-05 · Method Pharmaceuticals LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 58657-0930-10 · not listed as a package in the FDA directory · $0.06798 per EA · eff. 2026-09-23 filed
- 60687-0804-11 · not listed as a package in the FDA directory · $0.06798 per EA · eff. 2026-09-23 filed
- 60687-0804-65 · American Health Packaging · $0.06798 per EA · eff. 2026-09-23 filed
- 62135-0472-90 · Chartwell RX, LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 70710-1609-01 · Zydus Pharmaceuticals (USA) Inc. · $0.06798 per EA · eff. 2026-09-23 filed
- 70756-0085-11 · Lifestar Pharma LLC · $0.06798 per EA · eff. 2026-09-23 filed
- 71930-0066-12 · Eywa Pharma Inc · $0.06798 per EA · eff. 2026-09-23 filed
- 72888-0009-01 · Advagen Pharma Limited · $0.06798 per EA · eff. 2026-09-23 filed
- 84386-0035-01 · Aurobindo Pharma Limited · $0.06798 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name baclofen with BACLOFEN 5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BACLOFEN 5 MG TABLET this page | $0.06798 per EA filed | $0.18654 per EA filed |
| BACLOFEN 5 MG/5 ML SOLUTION | $1.07017 per ML filed | We don’t know yet |
| BACLOFEN 10 MG TABLET | $0.03199 per EA filed | $0.18654 per EA filed |
| BACLOFEN 10 MG/5 ML SOLUTION | $2.04441 per ML filed | We don’t know yet |
| BACLOFEN 15 MG TABLET | $1.66662 per EA filed | $0.18654 per EA filed |
| BACLOFEN 20 MG TABLET | $0.05185 per EA filed | $0.18654 per EA filed |
| BACLOFEN 25 MG/5 ML SUSPENSION | $3.76436 to $3.78853 per ML filed | We don’t know yet |
| FLEQSUVY 25 MG/5 ML SUSPENSION | $5.98153 per ML filed | $5.25798 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 20 NDCs’ NADAC prices is $0.06798 per EA filed.
Of the 7 other products in FDA’s gamma-Aminobutyric Acid-ergic Agonist class priced per EA, 3 have a higher middle NADAC price and 4 a lower one. The one in the middle is BACLOFEN 20 MG TABLET, at $0.05185 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $5.60 for 30 tablets, at an average of $0.18654 per EA in 2024 (2024-01-01 to 2024-12-31) for “Baclofen*” and “Baclofen”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 5,180,407 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
19 of the product’s 20 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for BACLOFEN 5 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Baclofen* / Baclofen: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (113 of the 127 the name join matched); NDCs of another route or with no known FDA route do not. 9 of the 113 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 119 of 127 NADAC NDCs joined to this name are priced per EA (8 per ML): CMS's average mixes those units.